Download Citation
Article Source:
Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3
Alsiö Å,
Rembeck K,
Askarieh G,
Christensen PB,
Färkkilä M,
et al.
(2012)
Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or 3.
PLOS ONE 7(5): e37521.
https://doi.org/10.1371/journal.pone.0037521